dr. ai on the efficacy of brentuximab vedotin in patients with advanced cutaneous t-cell lymphoma
Published 6 years ago • 288 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
0:41
dr. brammer on fda approval of brentuximab vedotin in ctcl
-
1:25
dr. brammer on brentuximab vedotin for patients with t-cell lymphoma
-
1:05
dr. ai on the fda approval of mogamulizumab in ctcl
-
1:19
dr. smith discusses brentuximab vedotin in ctcl
-
1:01
dr. ai on potential with mogamulizumab in ctcl
-
1:30
dr. william on brentuximab vedotin/lenalidomide in cutaneous/peripheral t-cell lymphomas
-
2:43
hodgkin lymphoma: using brentuximab vedotin frontline
-
0:57
dr. flinn on fda approval of frontline brentuximab vedotin with avd in hodgkin lymphoma
-
1:13
fda approval of brentuximab vedotin plus avd in classical hodgkin lymphoma
-
1:31
dr. moskowitz on the alcanza trial in ctcl
-
1:15
dr. humphrey on mogamulizumab for cutaneous t-cell lymphoma
-
1:58
mavoric trial in cutaneous t-cell lymphoma
-
15:19
an introduction to therapies for cutaneous t-cell lymphoma
-
3:38
brentuximab vedotin overview and treatment advice
-
13:33
cutaneous lymphoma 101
-
1:29
current treatment landscape & unmet needs in cutaneous t-cell lymphoma: quality of life
-
11:40
what is cutaneous t cell lymphoma?
-
1:00
the future of cutaneous t-cell lymphoma treatment
-
1:59
answers from the experts: long term expectations with alcl